Disappointing. Latest CE Mark guesstimate was end-2017, now looks like mid-2018 at best. Only guarantee is that any revenues from CE Mark certification will arrive too late to avoid another "working capital" capital raise, as only $2m in cash reserves forecast by end-March.
So looks like:
1. Raise more funds to get through to CE Mark.
2. Hopefully get CE Mark and start making sales.
3. Raise further funds to execute OncoPac-1.
Its going to be a hard task raising funds for 1, given the shredded credibility with the whole CE Mark 5+ year debacle. No guarantee the company will ever get to 3.
Looks too risky now ...
Disappointing. Latest CE Mark guesstimate was end-2017, now...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.160(15.7%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.18 | $1.03 | $51.49K | 47.06K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2041 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 830 | 1 |
View Market Depth
| Last trade - 15.27pm 26/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |